PPARG and type 2 diabetes mellitus: Additionally, PPARγ has been reported to be the central regulator of adipocyte differentiation, important in regulating lipid metabolism and glucose homeostasis [47,48,49] and Wang et al. [46] suggested that agonists of PPARγ could be therapeutically considered to counter hyperglycemia elicited due to type 2 diabetes.